Tobacco News and Research

RSS

Laws that end smoking result in fewer hospitalizations for heart attacks, strokes

Laws that end smoking at work and other public places result in significantly fewer hospitalizations for heart attacks, strokes, asthma and other respiratory conditions, a new UCSF analysis has found.

7 Nov 2012

Pfizer receives FDA approval for Xeljanz to treat rheumatoid arthritis

The U.S. Food and Drug Administration today approved Xeljanz (tofacitinib) to treat adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to, or who are intolerant of, methotrexate.

6 Nov 2012

No link between daily multivitamin use and reduction of major cardiovascular events in men

In a randomized study that included nearly 15,000 male physicians who were middle-aged or older, daily multivitamin use for more than 10 years of treatment and follow-up did not result in a reduction of major cardiovascular events, heart attack, stroke, or death from cardiovascular disease, according to a study appearing in November 7 issue of JAMA, a theme issue on cardiovascular disease.

5 Nov 2012

Smoke-free laws lead to fewer heart attacks

A recent decline in the incidence of myocardial infarction in Olmsted County, Minnesota, USA, could be due to the implementation of smoke-free laws, researchers suggest.

5 Nov 2012

New studies support limiting daily sodium consumption to less than 1,500mg

New studies support limiting daily sodium consumption to less than 1,500 milligrams, according to a new American Heart Association presidential advisory.

3 Nov 2012

FDA expands Janssen’s Xarelto use to reduce risk of DVT and PE

The U.S. Food and Drug Administration today expanded the approved use of Xarelto (rivaroxaban) to include treating deep vein thrombosis (DVT) or pulmonary embolism (PE), and to reduce the risk of recurrent DVT and PE following initial treatment.

3 Nov 2012

Australia's Generation X on the path to become more obese than baby boomers

New research from the University of Adelaide shows that Australia's Generation X is already on the path to becoming more obese than their baby boomer predecessors.

2 Nov 2012

Encouraging results from Gilead’s TAF Phase 2 trial on HIV-1 infection

Gilead Sciences, Inc. today announced that a Phase 2 clinical trial evaluating tenofovir alafenamide fumarate, an investigational novel prodrug of tenofovir for the treatment of HIV-1 infection, met its primary objective.

1 Nov 2012

University of Sheffield scientists reveal secrets of DNA repair

Scientists from the University of Sheffield have unlocked one of the secrets to DNA repair -helping doctors identify DNA base damage and a patient's susceptibility to certain types of cancer.

1 Nov 2012

Physically active men produce better semen quality

A new study conducted by researchers at the University of Cordoba links moderate physical activity in males with better hormone levels and sperm characteristics that favour reproduction compared to sedentary men.

1 Nov 2012

Smoke-free laws lead to fewer heart attacks

A recent decline in the incidence of myocardial infarction in Olmsted County, Minnesota, USA, could be due to the implementation of smoke-free laws, researchers suggest.

31 Oct 2012

Trait impulsivity linked to smoking initiation in bipolar disorder

Trait impulsivity is associated with the initiation, but not maintenance, of smoking in patients with bipolar disorder, study results suggest.

30 Oct 2012

Nearly 75% of Hoosiers support indoor workplace smoking ban

Public health researchers examining data from an Indiana Adult Tobacco Survey found nearly 75 percent of Hoosiers support a statewide or community indoor workplace smoking ban.

30 Oct 2012

Adolescent males at increased risk of reporting longtime OTC drug use

As crackdowns get tougher on alcohol, tobacco sales, and illicit drugs, there's a growing trend among youth to turn to another source to get a high: their parent's medicine cabinet. A new University of Cincinnati study suggests adolescent males are at a higher risk of reporting longtime use of over-the-counter drugs, compared with their female peers.

30 Oct 2012

Smoke-free legislation associated with fewer hospitalizations

Smoke-free legislation was associated with substantially fewer hospitalizations and deaths from heart and respiratory diseases, according to research in the American Heart Association journal Circulation.

30 Oct 2012

C allele of rs1329650 may increase risk of both ADHD and smoking

A variation of a particular gene may link the behaviours typical of childhood attention hyperactivity disorder, or ADHD for short, and those associated with smoking, suggests research published online in the Archives of Disease in Childhood.

30 Oct 2012

Female smokers who stop before middle age on average gain ten extra years of life

The largest-ever study of the hazards of smoking and benefits of stopping for women in the UK has shown that female smokers lose at least ten years of lifespan, but that stopping before the age of 40, and preferably well before the age of 40, avoids more than 90% of the increased risk of dying caused by continuing to smoke, while stopping before the age of 30 avoids over 97% of it.

29 Oct 2012

Routine ECG can help doctors identify patients at higher risk of adverse cardiovascular outcomes

Canadian scientists have determined that routine electrocardiogram results for patients with atrial fibrillation - the most common form of irregular heart beat - can help doctors identify those at higher risk of adverse cardiovascular outcomes, including death.

29 Oct 2012

Pfizer receives FDA approval for Synribo to treat chronic myelogenous leukemia

The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.

29 Oct 2012

EU Tobacco Products Directive further delayed

The EU’s revised Tobacco Products Directive – which was set to place substantial new restrictions on tobacco companies’ promotion of cigarettes and smokeless tobacco, including banning “e-cigarettes” – is dangerously close to stalling, and “further delay will raise serious questions about whose interest the EU Commission is promoting”, according to the authors of a Comment, published in The Lancet.

26 Oct 2012